<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        24-498-08
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2008
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOPRAM 20MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CITALOPRAM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        72.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="OMAN PHARMACEUTICAL PRODUCTS" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06AB04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How does </strong><strong>Lopram work?</strong></p><p>Lopram is a Selective Serotonin Reuptake Inhibitor (SSRI) and belongs to a group of medicines known as antidepressants. These medicines help to correct certain chemical imbalances in the brain that are causing the symptoms of your illness.</p><p><strong>What is </strong><strong>Lopram used for?</strong></p><p>Lopram contains citalopram and is used for the treatment of depression and, when you feel better, to help prevent these symptoms recurring. Lopram is also used for long-term treatment to prevent the occurrence of new episodes of depression if you have recurrent depression.</p><p>Lopram is also beneficial in relieving symptoms if you tend to suffer from panic attacks.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take </strong><strong>Lopram</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to citalopram or to any of the other ingredients of this medicine (listed in section 6). Consult your doctor if you think you might be.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; at the same time as taking medication known as monoamine oxidase inhibitors (MAOIs). MAOIs include medicines such as phenelzine, iproniazid, isocarboxazid, nialamide, tranylcypromine and moclobemide (used for the treatment of depression), selegiline (used in the treatment of Parkinson&rsquo;s disease) and linezolid (an antibiotic). Even if you have finished taking one of the following MAOIs: phenelzine, iproniazid, isocarboxazid, nialamide or tranylcypromine you will need to wait 2 weeks before you start taking your &nbsp;Lopram tablets. One day must elapse after you have finished taking moclobemide. After stopping Lopram you must allow 1 week before taking any MAOI.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are born with or have had an episode of abnormal heart rhythm (seen at ECG; an examination to evaluate how the heart is functioning).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you take medicines for heart rhythm problems or that may affect the heart&rsquo;s rhythm (see <strong>Other medicines and Lopram </strong>below).</p><p><strong>Warnings and precautions</strong></p><p>Please tell your doctor if you have any medical problems, especially if you have</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; History of bleeding disorders or have ever suffered from bleeding in the stomach or intestine, or if you are pregnant (see &lsquo;Pregnency, breast-feeding and fertility&rsquo;)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes (you may need an adjustment of your antidiabetic therapy).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Epilepsy or a history of seizures or fits.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mania or panic disorder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood levels of sodium</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ECT (electroconvulsive therapy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Suffered or suffer from heart problems or have recently had a heart attack.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A low resting heart-rate and/or you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting (being sick) or usage of diuretics (water tablets).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Experienced a fast or irregular heartbeat, fainting, collapse or dizziness on standing up which may indicate abnormal functioning of the heart rate.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have or have previously had eye problems, such as certain kinds of glaucoma (increased pressure in the eye).</p><p>Please consult your doctor, even if these statements were applicable to you at any time in the past.</p><p><strong>Please note:</strong></p><p>Some patients with manic-depressive illness may enter into a manic phase. This is characterized by unusual and rapidly changing ideas, inappropriate happiness and excessive physical activity. If you experience this, contact your doctor.</p><p>Symptoms such as restlessness or difficulty in sitting or standing still can also occur during the first weeks of the treatment. Tell your doctor immediately if you experience these symptoms. Medicines like Lopram (so called SSRIs/SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have continued after stopping treatment.</p><p><strong>Special information relating to your disease</strong></p><p>As with other medicines used to treat depression or related diseases, the improvement is not achieved immediately. After the start of Lopram treatment it may take several weeks before you experience any improvement. In the beginning of the treatment certain patients may experience increased anxiety, which will disappear during continued treatment. Therefore, it is very important that you follow exactly your doctor&rsquo;s orders and do not stop the treatment or change the dose without consulting your doctor.</p><p>&nbsp;</p><p><strong>Thoughts of suicide and worsening of your depression or anxiety disorder</strong></p><p>If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.</p><p>You may be more likely to think like this:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have previously had thoughts about killing or harming yourself.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are a <strong>young adult</strong>. Information from clinical trials has shown an increased risk of suicidal behaviour in adults aged less than 25 years with psychiatric conditions who were treated with an antidepressant.</p><p>If you have thoughts of harming or killing yourself at any time, <strong>contact your doctor or go to a hospital straight away.</strong></p><p><strong>You may find it helpful to tell a relative or close friend </strong>that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.</p><p><strong>Use in children and adolescents under 18 years of age</strong></p><p>Lopram should normally not be used for children and adolescents under 18 years. Also, you should know that patients under 18 have an increased risk of side effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. Despite this, your doctor may prescribe citalopram for patients under 18 because he/she decides that this is in their best interests. If your doctor has prescribed Lopram for a patient under 18 and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking Lopram. Also, the long-term safety effects concerning growth, maturation and cognitive and behavioural development of Lopram in this age group have not yet been demonstrated.</p><p><strong>Other medicines and Lopram</strong></p><p>Medicines may affect the action of other medicines and this can sometimes cause serious adverse reactions. Please tell your doctor or pharmacist if you are taking, have taken or might take any other medicines. This includes other medicines for depression (see <strong>Do not take Lopram</strong>).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The herbal remedy St John&rsquo;s wort (<em>Hypericum perforatum</em>). This should not be taken at the same time as Lopram.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Monoamine oxidase inhibitors (MAOIs). These should not be taken at the same time as Lopram (see <strong>Do not take Lopram </strong>above).</p><p>Tell your doctor if you are taking any of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Linezolid (an antibiotic).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sumatriptan (used to treat migraine) or tramadol and buprenorphine and similar medicines (strong pain killers). Taking these medicines together with Lopram can lead to serotonin syndrome, a potentially life-threathening condition. The syndrome may be associated with symptoms such as involuntary, rhythmic contractions of muscles, including the muscles that control movement of th eye, agitation, hallucinations, coma, excessive sweating, tremor, exaggeration of reflexes, increased muscle tension, body temperature above 38&deg;C. Contact your doctor when experiencing such symptoms.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lithium (used to prevent and treat mania) and tryptophan (an antidepressant).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pimozide (a neuroleptic). This should not be taken at the same time as Lopram.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Imipramine and desipramine (used to treat depression).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines containing selegiline (used to treat Parkinson&rsquo;s disease).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cimetidine, lansoprazole and omeprazole (used to treat stomach ulcers), fluconazole (used to treat fungal infections), fluvoxamine (antidepressant) and ticlopidine (used to reduce the risk of stroke). These may cause increased blood levels of citalopram.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mefloquine (used to treat malaria).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bupropion (used to treat depression).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines known to affect the blood platelets (e.g. anticoagulant drugs used to treat or prevent blood clots; aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac used as painkillers and some antipsychotic drugs and tricyclic antidepressants).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metoprolol, a beta blocker used to treat migraine, some heart conditions and high blood pressure. The effects of either drug could be increased, decreased or altered.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neuroleptics (used in the treatment of schizophrenia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strong and moderate inhibitors of CYP2C19 may result in increased exposure to N-desmethylclobazam, the active metabolite of clobazam. This may increase the risk of dose-related adverse reactions.</p><p><strong>Do not take Lopram </strong>if you take medicines for heart rhythm problems or medicines that may affect the heart&rsquo;s rhythm, e.g. such as Class IA and III antiarrhythmics, antipsychotics (e.g. phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, certain antimicrobial agents (e.g. sparfloxacin, moxifloxacin, erythromycin IV, pentamidine,</p><p>anti-malarial treatment particularly halofantrine), certain antihistamines (astemizole, mizolastine). If you have any further questions about this you should speak to your doctor.</p><p><strong>Taking Lopram with food, drink and alcohol</strong></p><p>Lopram can be taken with or without food (see section 3 <strong>&ldquo;How to take Lopram&rdquo;</strong>).</p><p>As with all antidepressants, it is sensible to avoid drinking alcohol whilst receiving treatment although Lopram has not been shown to increase the effects of alcohol.</p><p><strong>Pregnancy</strong></p><p>If you take Lopram near the end of your pregnancy there may be an increased risk of heavy vaginal bleeding shortly after birth, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking Lopram so they can advise you.</p><p>&nbsp;</p><p>Ask your doctor or pharmacist for advice before taking any medicine. If you are pregnant, think you might be pregnant, or are trying to become pregnant, tell your doctor. Do not take Lopram if you are pregnant unless you and your doctor have discussed the risks and benefits involved.</p><p>Make sure your midwife and/or doctor know you are on Lopram. When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like Lopram may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately. Also, if you take Lopram during the last 3 months of your pregnancy and until the date of birth you should be aware that the following effects may be seen in your newborn: fits, being too hot or cold, feeding difficulties, vomiting, low blood sugar, stiff or floppy muscles, overactive reflexes, tremor, jitteriness, irritability, lethargy, constant crying, sleepiness or sleeping difficulties. If your newborn baby gets any of these symptoms please contact your midwife and/or doctor immediately.</p><p><strong>Breast-feeding</strong></p><p>Ask your doctor or pharmacist for advice before taking any medicine. If you are breast-feeding, ask your doctor for advice. You should not breast-feed your baby when taking Lopram because small amounts of the medicine can pass into the breast milk.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>Citalopram has been shown to reduce the quality of sperm in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet.</p><p><strong>Driving and using machines</strong></p><p>Lopram does not usually affect the ability to carry out normal daily activities. However, if you feel dizzy or sleepy when you start to take this medicine, you should be careful when driving, operating machinery or performing jobs that need you to be alert until these effects wear off</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How much to take</strong></p><p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Adults</strong></p><p><u>Depression </u></p><p>The usual dose is 20 mg per day. This may be increased by your doctor to a maximum of 40 mg per day.</p><p>&nbsp;</p><p><u>Panic disorder</u></p><p>The starting dose is 10 mg per day for the first week before increasing the dose to 20-30 mg per day. The dose may be increased by your doctor to a maximum of 40 mg per day.</p><p><strong>Elderly patients (above 65 years of age)</strong></p><p>The starting dose should be decreased to half of the recommended dose, e.g. 10-20 mg per day. Elderly patients should not usually receive more than 20 mg per day.</p><p><strong>Children and adolescents (less than 18 years of age)</strong></p><p>Lopram should not be given to children or adolescents. For further information, please see section 2, <strong>What you need to know before you take Lopram</strong>.</p><p><strong>Patients with special risks</strong></p><p>Patients with liver complaints should not receive more than 20 mg per day.</p><p><strong>How and when to take Lopram</strong></p><p>Lopram is taken every day as a single daily dose. Lopram can be taken any time of the day with or without food. Swallow the tablets with a drink of water. Do not chew them (they have a bitter taste).</p><p><strong>Duration of treatment</strong></p><p>Like other medicines for depression and panic disorder these tablets may take a few weeks before you feel any improvement. Continue to take Lopram even if it takes some time before you feel any improvement in your condition. The duration of treatment is individual, usually at least 6 months. Continue to take the tablets for as long as your doctor recommends. Do not stop taking them even if you begin to feel better, unless you are told to do so by your doctor. The underlying illness may persist for a long time and if you stop your treatment too soon your symptoms may return.</p><p>Patients who have recurrent depression benefit from continued treatment, sometimes for several years, to prevent the occurrence of new depressive episodes.</p><p>Never change the dose of the medicine without talking to your doctor first.</p><p><strong>If you take more Lopram than you should</strong></p><p>If you think that you or anyone else may have taken too many Lopram tablets contact your doctor or nearest hospital emergency department immediately. Do this even if there are no signs of discomfort or poisoning. Take the Lopram box/container with you if you go to a doctor or hospital. Some of the signs of an overdosage could be life-threatening.</p><p>Symptoms of overdosage may include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Irregular heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seizures</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in heart rhythm</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sweating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drowsiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unconsciousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fast heart beats</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serotonin syndrome (see Section 4)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agitation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enlarged eye pupils</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bluish skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Breathing too quickly</p><p><strong>If you forget to take Lopram</strong></p><p>If you forget to take a dose, take the next dose at the usual time. Do not take a double dose.</p><p><strong>Effects when treatment with Lopram is stopped</strong></p><p>Stopping this medicine quickly may cause symptoms such as dizziness, nausea and numbness or tingling in hands or feet, sleep disturbances (vivid dreams, nightmares, inability to sleep), feeling anxious, headaches, feeling or being sick, sweating, feeling restless or agitated, tremor, feeling confused or disorientated, feeling emotional or irritable, diarrhoea (loose stools), visual disturbances, fluttering or pounding heartbeat (palpitations). These are usually non-serious and disappear within a few days. When you have completed your course of treatment, the dose of Lopram is usually reduced gradually over a couple of weeks.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines this medicine can cause side effects, although not everybody gets them. Several of the effects listed below can also be symptoms of your illness and may disappear as you start to get better.</p><p><strong>Serious side effects</strong></p><p>Stop taking Lopram and seek medical advice immediately if you have any of the following symptoms:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty in breathing.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the face, lips, tongue or throat that causes difficulty in swallowing or breathing.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe itching of the skin (with raised lumps).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fast, irregular heartbeat, fainting which could be symptoms of a life-threatening condition known as torsades de pointes.</p><p>If you notice any of the following symptoms you should contact your doctor immediately as your dose may need to be reduced or stopped:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You start having fits for the first time or fits that you have suffered from in the past become more frequent.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your behaviour changes because you feel elated or over excited.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You experience high fever, agitation, confusion, trembling or abrupt contractions of muscles. These may be signs of a rare condition called serotonin syndrome.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness, confusion and twitching of your muscles. These may be signs of a low blood level of sodium (hyponatraemia).</p><p>If you have thoughts of harming or killing yourself at any time, <strong>contact your doctor or go to a hospital straight away.</strong></p><p>The following side effects are often mild and usually disappear after a few days&rsquo; treatment.</p><p>Very common side effects (may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleepiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty in sleeping</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in your sleeping pattern</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of body strength, weakness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sweating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry mouth (a dry mouth increases the risk of tooth decay, so be sure to clean your teeth more often than usual)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea)</p><p>Common side effects (may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lack of appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Agitation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decreased sex drive</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anxiety</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nervousness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal dreams</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced emotions, indifference (apathy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tingling or numbness in the hands or feet</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems concentrating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Migraine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of memory (amnesia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ringing in the ears (tinnitus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Palpitations</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yawning</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blocked or runny nose (rhinitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flatulence (wind)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in saliva (drooling)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in muscles and joints</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For men, problems with ejaculation and erection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For women, failing to reach an orgasm</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prickling of the skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of weight</p><p>Uncommon (may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bruising easily</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aggression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hallucinations</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mania</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fainting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Large pupils (the dark centre of the eye)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fast heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slow heart beat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nettle rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of hair</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sensitivity to sunlight</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulties urinating</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Excessive menstrual bleeding</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling of the arms or legs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased weight</p><p>Rare (may affect up to 1 in 1000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sex drive</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Convulsions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Involuntary movements</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taste disturbances</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coughing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling unwell (malaise)</p><p>Some patient have reported (frequency not known)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heavy vaginal bleeding shortly after birth (postpartum haemorrhage), see &lsquo;Pregnancy, breast-feeding and fertility&rsquo; in section 2 for more information.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thoughts of harming or killing themselves, see also section 2 &ldquo;<strong>What you need to know before you take Lopram</strong>&rdquo;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increase in bleeding or bruising caused by a decrease in blood platelets (thrombocytopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rash (hypersensitivity)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low potassium levels in the blood (hypokalaemia), which can cause muscle weakness, twitching or abnormal heart rhythms</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in a hormone called prolactin in the blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Panic attack</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Grinding teeth</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restlessness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusual muscle movements or stiffness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Involuntary movements of the muscles (akathisia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nosebleed</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding disorders including skin and mucosal bleeding (ecchymosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden swelling of skin or mucosa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In men, painful erections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flow of breast milk in men or in women who are not breast-feeding (galactorrhoea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Irregular menstrual periods</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal liver function tests</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increased risk of bone fractures has been observed in patients taking this type of medicines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal heart rhythm</p><p>SSRIs can, very rarely, increase the risk of bleeding, including stomach or intestinal bleeding. Let your doctor know if you vomit blood or develop black or blood stained stools.</p><p>&nbsp;</p><p>Also let your doctor know if you continue to have other symptoms associated with your depression. This might include hallucinations, anxiety, mania or confusion.</p><p>Any side effects that do occur will usually disappear after a few days. If they are troublesome or persistent, or if you develop any other unusual side effects while taking Lopram, please tell your doctor.</p><p>&nbsp;</p><p><strong>To report any side effect(s): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong>:</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30&deg;C. Protect from light and moisture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach of the children.</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the label or carton. The expiry date refers to the last day of that month.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is citalopram (as hydrobromide). Each Lopram film-coated tablets contain 20 mg citalopram.</p><p>The other ingredients are mannitol, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate, purified water, hypromellose, titanium dioxide &amp; macrogol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                The 20 mg tablets are white to off white, oval shaped, biconvex, film coated tablets having deep break line engraved on one side and LM monogram engraved on the other side.
The tablets are available in Aluminium/PVC blister pack of 14 tablets. Two blisters packed in a carton.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Oman pharmaceutical Products Co., L.L.C, Plot no 108 Raysut Industrial city, P.O Box 2240 Postal code 211 Salalah,Sultanate of Oman</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>كيف يعمل لوبرام؟ </strong></p><p dir="RTL">لوبرام هو مانع انتقائي لإمتصاص السيروتونين (SSRI) وينتمي إلى مجموعة من الأدوية المعروفة باسم مضادات الاكتئاب. هذه الأدوية تساعد على تصحيح اختلالات كيميائية معينة في الدماغ التي تسبب أعراض مرضك.</p><p dir="RTL"><strong>في ماذا يستخدم لوبرام؟ </strong></p><p dir="RTL">لوبرام يحتوي على سيتالوبرام ويستخدم لعلاج الاكتئاب، حتى عندما تشعر أنك أفضل، فإنه يساعد في منع تكرر هذه الأعراض المتكررة. يستخدم لوبرام أيضا للعلاج على المدى الطويل لمنع وقوع حوادث جديدة من الاكتئاب إذا كان لديك الاكتئاب المتكرر.</p><p dir="RTL">لوبرام مفيد أيضا في تخفيف الأعراض إذا كنت تميل إلى تعاني من نوبات الهلع.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تأخذ لوبرام </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية لسيتالوبرام أو إلى أي من المكونات الأخرى من هذا الدواء (المدرجة في القسم 6). استشر طبيبك إذا كنت تعتقد ذلك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في نفس الوقت عند تناول الدواء المعروف باسم مثبطات أوكسيديز أحادي الأمين (MAOIs). MAOIs تشمل الأدوية مثل فينلزين، إيبرونيازيد، إيزوكربوكسازيد، نيالاميد، ترانيلسيبرومين وموكلوبميد (التي تستخدم لعلاج الاكتئاب) ، سيليجيلين (المستخدمة في علاج مرض باركنسون) وينزوليد (مضاد حيوي). حتى لو كنت قد انتهيت من اتخاذ واحد من &nbsp;مثبطات أوكسيديز أحادي الأمين التالية: فينلزين، إيبرونيازيد، إيزوكربوكسازيد، نيالاميد أو ترانيلسيبرومين سوف تحتاج إلى الانتظار 2 أسابيع قبل البدء بتناول أقراص لوبرام الخاص بك. يجب الانتظار ليوم واحد بعد الانتهاء من اتخاذ موكلوبميد. بعد وقف من تناول لوبرام يجب الانتظار لمدة &nbsp;1 أسبوع قبل اتخاذ أي من MAOI.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت ولدت مع أو كان لها حالة من ضربات القلب الغير طبيعية (ينظر في تخطيط القلب، فحص لتقييم كيف يعمل القلب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تأخذ أدوية لمشاكل ضربات القلب أو التي قد تؤثر ضربات القلب (انظر الأدوية الأخرى ولوبرام أدناه).</p><p dir="RTL"><strong>التحذيرات والاحتياطات </strong></p><p dir="RTL">يرجى إخبار الطبيب إذا كان لديك أي مشاكل طبية، وخاصة إذا كان لديك:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تاريخ من اضطرابات النزيف أو إذا كنت قد عانيت من نزيف في المعدة أو الأمعاء، أو إذا كنت حاملاً (انظر قسم &#39;الحمل والرضاعة والخصوبة&#39;).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الكبد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمراض الكلى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكري (قد تحتاج إلى تعديل العلاج المضادة لمرض السكر الخاص بك).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصرع أو تاريخ من التشنجات أو النوبات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب النزيف أو عانيت في أي وقت مضى من نزيف في المعدة أو الأمعاء.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SSRIs/SNRIs قد تزيد من خطر حدوث نزيف ما بعد الولادة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهوس أو اضطراب الهلع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الصوديوم في الدم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاج بالصدمات الكهربائية (العلاج بالصدمة الكهربائية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في عينيك، مثل أنواع معينة من الزرق.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عانيت أو تعاني من مشاكل في القلب أو لديك مؤخرا نوبة قلبية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; معدل وقت الاستراحة بين ضربات القلب منخفض و / أو كنت تعرف أنك قد يحصل لديك نضوب الملح نتيجة الإسهال الشديد والقيء لفترات طويلة (بسبب الارجاع) أو استخدام مدرات البول (أقراص الماء).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرضت لضربات القلب سريعة أو غير منتظمة، والاغماء، وانهيار أو الدوخة عند الوقوف والتي قد تشير إلى عمل غير طبيعي في معدل ضربات القلب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو عانيت من قبل من مشاكل في العين ، مثل أنواع معينة من الجلوكوما (زيادة الضغط في العين).</p><p dir="RTL">يرجى استشارة طبيبك، حتى لو كانت هذه البيانات تنطبق عليك في أي وقت مضى.</p><p dir="RTL"><strong>يرجى ملاحظة ما يلي: </strong></p><p dir="RTL">بعض المرضى الذين يعانون من مرض الهوس الاكتئابي قد يدخل إلى مرحلة الهوس. تتميز هذه المرحلة بالأفكار الغير عادية وسريعة التغير، والسعادة الغير مناسبة وممارسة النشاط البدني المفرط. إذا واجهت هذه، اتصل بطبيبك.</p><p dir="RTL">أعراض مثل الأرق أو صعوبة في الجلوس أو الوقوف لا يزال يمكن أيضا أن تحدث خلال الأسابيع الأولى من العلاج. أخبر طبيبك فورا إذا واجهت هذه الأعراض.</p><p dir="RTL"><strong>معلومات خاصة تتعلق مرضك </strong></p><p dir="RTL">كما هو الحال مع الأدوية الأخرى المستخدمة لعلاج أمراض الاكتئاب أو ذات الصلة، لا يتحقق التحسن فورا. بعد بدء العلاج بلوبرام قد يستغرق عدة أسابيع قبل أن تشهد أي تحسن. في بداية العلاج بعض المرضى قد تواجه زيادة القلق، والتي سوف تختفي خلال استمرار العلاج. وبالتالي، فمن المهم جدا أن تتبع بالضبط أوامر الطبيب ولا توقف العلاج أو تغيير الجرعة دون استشارة الطبيب.</p><p dir="RTL"><strong>أفكار الانتحار وتفاقم اضطراب الاكتئاب أو القلق لديك </strong></p><p dir="RTL">إذا كنت مكتئبا و / أو لديهم اضطرابات القلق يمكن أن يكون في بعض الأحيان تظهر لديك أفكار إيذاء أو قتل نفسك. هذه يمكن تزيد عند الاستعمال الأول لمضادات الاكتئاب، لأن هذه الأدوية تأخذ بعض الوقت ليظهر تأثيرها، عادة حوالي أسبوعين لكن في بعض الأحيان لفترة أطول.</p><p dir="RTL">قد تكون أكثر عرضة للتفكير من هذا القبيل:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك سابقا الأفكار حول قتل أو إيذاء نفسك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت من الشباب البالغين. وقد أظهرت المعلومات المستقاة من التجارب السريرية زيادة خطر السلوك الانتحاري لدى البالغين الذين تقل أعمارهم عن 25 عاما يعانون من حالات نفسية والذين عولجوا مع مضاد للاكتئاب.</p><p dir="RTL">إذا كان لديك أفكار إيذاء أو قتل نفسك في أي وقت، <strong>اتصل بطبيبك أو اذهب إلى المستشفى على الفور. </strong></p><p dir="RTL"><strong>قد تجد أنه من المفيد أن تبلغ صديق مقرب أو أحد الأقارب</strong> أنك مكتئب أو لديك اضطرابات القلق، وتطلب منهم قراءة هذه النشرة. قد نطلب منهم يبلغوك إذا كانوا يعتقدون أن الاكتئاب أو القلق يزداد سوءا، أو إذا انهم قلقون بشأن التغيرات في السلوك الخاص بك.</p><p dir="RTL"><strong>الاستخدام في الأطفال والمراهقين دون سن 18 سنة من العمر </strong></p><p dir="RTL">لوبرام عادة لا ينبغي استخدامه للأطفال والمراهقين دون سن 18 عاما. أيضا، يجب أن نعرف أن المرضى تحت سن 18 تزيد لديهم مخاطر الآثار الجانبية مثل محاولة الانتحار، وأفكار انتحارية والعداء (في الغالب العدوان، السلوك الاعتراضي والغضب) عندما تتناول هذه الفئة من الأدوية. على الرغم من هذا، فإن طبيبك قد يصف سيتالوبرام للمرضى دون سن 18 لأنه / أنها قررت أن هذا هو في مصلحتهم. إذا طبيبك شرع لوبرام للمريض تحت 18 وتريد مناقشة هذا الموضوع، يرجى الرجوع إلى الطبيب. يجب إبلاغ الطبيب إذا كان أي من الأعراض المذكورة أعلاه تطورت أو تزداد سوءا عند المرضى الذين تقل أعمارهم عن 18 ويأخذون لوبرام. أيضا، لم يتم حتى الآن معرفة تأثيرات السلامة على المدى الطويل بشأن النمو والنضج والتنمية المعرفية والسلوكية مع لوبرام في هذه الفئة العمرية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ولوبرام الأدوية الأخرى </strong></p><p dir="RTL">الأدوية قد يؤثر على عمل بعض الأدوية الأخرى وهذا يمكن أن يسبب في بعض الأحيان ردود فعل سلبية خطيرة. يرجى إخبار الطبيب أو الصيدلي إذا كنت تأخذ، اتخذت أو قد تأخذ أي أدوية أخرى. وهذا يشمل الأدوية الأخرى لعلاج الاكتئاب (انظر <strong>لا تأخذ لوبرام أعلاه</strong>).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاجات بالاعشاب نبتة سانت جون (بيرفوراتم هيبريكم). لا ينبغي أن يؤخذ في نفس الوقت مع لوبرام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أوكسيديز أحادي الأمين (MAOIs). لا ينبغي أن تؤخذ هذه في نفس الوقت لوبرام (انظر <strong>لا تأخذ لوبرام</strong> أعلاه).</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك إذا كنت تأخذ أي من الأدوية التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينزوليد (مضاد حيوي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوماتريبتان (يستخدم لعلاج الصداع النصفي) أو ترامادول وبوبرينورفين والأدوية المماثلة (مسكنات الألم القوية). تناول هذه الأدوية معًا مع لوبرام يمكن أن يؤدي إلى متلازمة السيروتونين، وهي حالة قد تكون مهددة للحياة. قد تكون المتلازمة مصحوبة بأعراض مثل تقلصات العضلات اللاإرادية والإيقاعية، بما في ذلك العضلات التي تتحكم في حركة العين، الإثارة، الهلوسة، الغيبوبة، التعرق المفرط، الارتعاش، المبالغة في ردود الفعل، زيادة توتر العضلات، درجة حرارة الجسم فوق 38&deg;C. اتصل بطبيبك عند مواجهة مثل هذه الأعراض.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوماتريبتان (التي تستخدم لعلاج الصداع النصفي) أو ترامادول (للألم). إذا كنت تشعر بتوعك عند استخدام هذه الأدوية مع لوبرام يجب عليك مراجعة الطبيب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليثيوم (التي تستخدم لعلاج ومنع الهوس)، والتربتوفان (مضاد للاكتئاب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بيموزيد (مُضادُّ الذُّهان). لا ينبغي أن يؤخذ هذا في نفس الوقت الذي لوبرام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيميبرامين وديسيبرامين (التي تستخدم لعلاج الاكتئاب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحتوي على سيليجيلين (تستخدم لعلاج مرض باركنسون)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السيميتيدين ، لانسوبرازول ، اومبرازول (التي تستخدم لعلاج قرحة المعدة) ، فلوكونازول (يستخدم لعلاج الالتهابات الفطرية) فلوفوكسامين (مضاد للاكتئاب) وتيكلوبيدين (يستخدم لتقليل مخاطر السكتة الدماغية). قد تسبب هذه زيادة مستويات الدم من سيتالوبرام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الميفلوكين (التي تستخدم لعلاج الملاريا).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البوبروبيون (التي تستخدم لعلاج الاكتئاب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المعروفة بتأثيرها على الصفائح الدموية (مثل العقاقير المضادة للتخثر يستخدم لعلاج أو منع تجلط الدم، والاسبرين والعقاقير المضادة للالتهابات غير الستيرويدية (المسكنات) مثل ايبوبروفين وديكلوفيناك التي تستخدم كمسكنات وبعض الأدوية المضادة للذهان ومضادات الاكتئاب الثلاثية الحلقات).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميتوبرولول، وحاصرات بيتا التي تستخدم لعلاج الصداع النصفي، وبعض أمراض القلب وارتفاع ضغط الدم. آثار الادوية إما يمكن زيادة، انخفض أو تغييرها.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مُضادُّ الذُّهان (المستخدمة في علاج الفصام).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تؤدي مثبطات CYP2C19 القوية والمعتدلة إلى زيادة التعرض لـ N-desmethylclobazam، وهو المستقلب النشط للكلوبازام. قد يزيد ذلك من خطر حدوث تفاعلات ضارة مرتبطة بالجرعة.</p><p dir="RTL"><strong>لا تتناول لوبرام</strong> إذا كنت تأخذ أدوية لمشاكل ضربات القلب أو الأدوية التي يمكن ان تؤثر ضربات القلب، على سبيل المثال مثل الفئة IA والثالثة &nbsp;من أدوية علاج ضربات القلب الغير منتظمة، مضادات الذهان (مثل مشتقات الفينوثيازين، بيموزيد، هالوبيريدول)، مضادات الاكتئاب الثلاثية الحلقات، وبعض العوامل المضادة للجراثيم (على سبيل المثال سَّبارفلوكساسين ، موكسيفلوكساسين، الاريثروميسين تسريب، بنتاميدين، الأدوية المضادة للملاريا العلاج خاصة هالوفانترين)، بعض مضادات الهستامين (استيميزول، ميزولاستين). إذا كان لديك أي أسئلة أخرى حول هذا يجب عليك التحدث مع طبيبك.</p><p dir="RTL"><strong>تناول لوبرام مع الطعام والشراب والكحول </strong></p><p dir="RTL">يمكن تناول لوبرام مع أو بدون طعام (انظر القسم 3 &quot;كيفية تناول لوبرام&quot;).</p><p dir="RTL">كما هو الحال مع جميع مضادات الاكتئاب، فمن المنطقي أن تتجنب شرب الكحول أثناء تلقي العلاج على الرغم من أنه لم يظهر لوبرام زيادة على تأثيرات الكحول.</p><p dir="RTL"><strong>الحمل </strong></p><p dir="RTL">إذا تناولت لوبرام قرب نهاية حملك، فقد يكون هناك خطر متزايد لحدوث نزيف مهبلي حاد بعد الولادة بفترة قصيرة، خاصة إذا كان لديك تاريخ من اضطرابات النزيف. يجب أن يكون طبيبك أو قابلتك على علم بأنك تتناولين لوبرام حتى يتمكنوا من تقديم النصائح المناسبة لك.</p><p dir="RTL">إسأل طبيبك أو الصيدلي للحصول على المشورة قبل اتخاذ أي دواء. إذا كنت حاملا، تعتقدين أنك قد تكون حاملا، أو تحاولي أن تصبحي حاملا، أخبري طبيبك. لا تأخذي لوبرام إذا كنت حاملا إلا إذا كنت والطبيب ناقشت المخاطر والمنافع المشتركة.</p><p dir="RTL">تأكيد من القابلات و / أو طبيب يعرفون أنك تتنتاولين لوبرام. عند تناوله خلال فترة الحمل، خاصة في الأشهر ال 3 الأخيرة من الحمل، الأدوية مثل لوبرام قد تزيد من خطر حدوث حالة خطيرة في الأطفال، وتسمى ارتفاع ضغط الدم الرئوي المستمر لحديثي الولادة (PPHN)، مما يجعل الطفل يتنفس بشكل أسرع ويظهر مزرق. عادة ما تبدأ هذه الأعراض خلال ال 24 ساعة الأولى بعد ولادة الطفل. إذا كان هذا يحدث لطفلك يجب عليك الاتصال بقابلتك و / أو الطبيب على الفور. أيضا، إذا كنت تأخذي لوبرام خلال 3 أشهر الأخيرة من الحمل وحتى تاريخ الولادة يجب عليك أن تدركي أن الآثار التالية قد تظهر في المولود: نوبات، أن يكون ساخن جدا أو بارد، صعوبات التغذية والقيء، وانخفاض سكر الدم ، وتصلب العضلات أو المرنة، وردود الفعل فرط نشاط، ورعاش، والعصبية، والتهيج، والخمول، والبكاء المستمر، والنعاس أو صعوبات النوم. إذا حصل &nbsp;أي من هذه الأعراض لمولودك الجديد يرجى الاتصال بقابلتك و / أو الطبيب على الفور.</p><p dir="RTL"><strong>الرضاعة الطبيعية </strong></p><p dir="RTL">إسألي طبيبك أو الصيدلي للحصول على المشورة قبل اتخاذ أي دواء. إذا كنت تقومين بالرضاعة الطبيعية، إسألي طبيبك للحصول على المشورة. يجب أن لا ترضعي طفلك عند تناول لوبرام لان كميات صغيرة من الدواء يمكن أن تنتقل إلى حليب الثدي.</p><p dir="RTL"><strong>الخصوبة </strong></p><p dir="RTL">تبين سيتالوبرام يحد من نوعية الحيوانات المنوية في الدراسات الحيوانية. من الناحية النظرية، وهذا يمكن أن يؤثر على الخصوبة، ولكن لم يلاحظ تأثير على الخصوبة البشرية حتى الآن.</p><p dir="RTL"><strong>القيادة واستخدام آلات</strong></p><p dir="RTL">لوبرام لا يؤثر عادة على القدرة في تنفيذ الأنشطة اليومية العادية. ومع ذلك، إذا كنت تشعر بالدوار أو النعاس عند البدء في تناول هذا الدواء، يجب أن تكون حذرا عند القيادة، وتشغيل الآلات، أو أداء الوظائف التي تحتاج منك أن تكون في حالة تأهب حتى تزول هذه الآثار</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كم الكمية التي يجب تناولها </strong></p><p dir="RTL">دائما تأخذ هذا الدواء تماما كما أبلغك طبيبك أو الصيدلي . تحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL"><strong>الكبار </strong></p><p dir="RTL"><u>الاكتئاب </u></p><p dir="RTL">الجرعة المعتادة هي 20 ملجم يوميا. يمكن زيادة من قبل الطبيب إلى حد أقصى قدره 40 ملجم يوميا.</p><p dir="RTL"><u>اضطراب الهلع </u></p><p dir="RTL">جرعة البداية هي 10 ملجم يوميا لمدة الأسبوع الأول قبل زيادة الجرعة إلى 20-30 ملجم يوميا. ويمكن زيادة الجرعة من قبل الطبيب إلى حد أقصى قدره 40 ملجم يوميا.</p><p dir="RTL"><strong>المرضى المسنين (فوق 65 سنة من العمر) </strong></p><p dir="RTL">يجب خفض الجرعة المبدئية لنصف الجرعة الموصى بها، على سبيل المثال 10-20 ملجم يوميا. المرضى كبار السن عادة ينبغي أن لا يأخذوا أكثر من 20 ملجم يوميا.</p><p dir="RTL"><strong>الأطفال والمراهقين (أقل من 18 سنة من العمر) </strong></p><p dir="RTL">لا ينبغي أن يعطى لوبرام للأطفال أو المراهقين. لمزيد من المعلومات، الرجاء مراجعة القسم 2، <strong>ما تحتاج إلى معرفته قبل اتخاذ لوبرام. </strong></p><p dir="RTL"><strong>المرضى الذين يعانون من مخاطر خاصة </strong></p><p dir="RTL">المرضى الذين يعانون من مشاكل الكبد يجب أن لا يأخذ أكثر من 20 ملجم يوميا.</p><p dir="RTL"><strong>كيف ومتى تتناول لوبرام </strong></p><p dir="RTL">يؤخذ لوبرام كل يوم كجرعة يومية واحدة. لوبرام يمكن تناوله في أي وقت من اليوم مع أو بدون الطعام. ابتلاع الافراص مع شربة ماء. لا تمضغهم (لديها طعم مر).</p><p dir="RTL"><strong>مدة العلاج </strong></p><p dir="RTL">مثل غيرها من الأدوية لعلاج الاكتئاب واضطراب الهلع هذه الاقراص قد يستغرق بضعة أسابيع قبل أن تشعر بأي تحسن. واصل في تناول &nbsp;لوبرام حتى لو استغرق ذلك بعض الوقت قبل أن تشعر بأي تحسن في حالتك. مدة العلاج الفردية، عادة ما لا يقل عن 6 أشهر. الاستمرار في تناول الأقراص لطالما يوصي بها الطبيب. لا تتوقف عن تناولها حتى إذا بدأت تشعر بالتحسن، إلا إذا قيل لك أن تفعل ذلك من قبل الطبيب.</p><p dir="RTL">قد يستمر المرض كامن لفترة طويلة وإذا توقفت عن العلاج بسرعة قد تعود الأعراض الخاصة بك.</p><p dir="RTL">المرضى الذين لديهم حالة الاكتئاب المتكررة يستفيدون من استمرار العلاج، وأحيانا لعدة سنوات، لمنع وقوع نوبات اكتئاب جديدة.</p><p dir="RTL">أبدا لا تغير جرعة الدواء قبل أن تتحدث مع طبيبك أولا.</p><p dir="RTL"><strong>إذا كنت تأخذ أكثر مما يجب من لوبرام </strong></p><p dir="RTL">إذا كنت تعتقد أنك أو أي شخص آخر قد اتخذت الكثير من أقراص لوبرام اتصل بالطبيب أو أقرب قسم الطوارئ في المستشفى فورا. قم &nbsp;بذلك حتى لو لم تكون هناك أي علامات الانزعاج أو التسمم. خذ شريط / عبوة &nbsp;لوبرام معك إذا ذهبت إلى الطبيب أو المستشفى. بعض من علامات على زيادة الجرعة قد تكون مهددة للحياة.</p><p dir="RTL">ويمكن أن تشمل أعراض الجرعة الزائدة:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام ضربات القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التشنجات</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في ضربات القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارجاع (الغثيان)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعرق</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النعاس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم الشعور</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دقات القلب سريعة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرعاش</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في ضغط الدم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة السيروتونين (انظر القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الانفعال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوخة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توسع حدقة العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجلد المزرق.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التنفس بسرعة كبيرة جدا</p><p dir="RTL"><strong>إذا كنت قد نسيت أن تأخذ لوبرام </strong></p><p dir="RTL">إذا كنت قد نسيت أن تأخذ جرعة، خذ الجرعة التالية في الوقت المعتاد. لا تأخذ جرعة مضاعفة.</p><p dir="RTL"><strong>آثار العلاج مع لوبرام عندما يتم إيقافه</strong></p><p dir="RTL">وقف هذا الدواء بسرعة قد يسبب أعراض مثل الدوخة، والغثيان، وخدر أو وخز في اليدين أو القدمين، واضطرابات النوم (أحلام اليقظة والكوابيس وعدم القدرة على النوم)، والشعور بالقلق، والصداع، والشعور بالإرجاع أو القيء، والتعرق، والشعور الضجر أو الاضطراب ، ورعاش، والشعور الحيرة أو التوهان ، والشعور العاطفي أو الانفعال، والإسهال (براز رخو)، اضطرابات بصرية، تهيج أو عنف ضربات القلب (خفقان). هذه عادة ما تكون غير خطيرة وتختفي في غضون أيام قليلة. عندما كنت قد تكمل مدة العلاج، وعادة ما يتم تخفيض جرعة من لوبرام تدريجيا على مدى أسبوعين.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام هذا المنتج، إسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية هذا الدواء يمكن أن يسبب آثار جانبية، وإن لم يكن الجميع تظهر لديهم. العديد من الآثار الواردة أدناه يمكن أيضا أن تكون أعراض مرضك وربما تختفي و تبدأ في التعافي .</p><p dir="RTL"><strong>آثار جانبية خطيرة </strong></p><p dir="RTL">التوقف عن تناول لوبرام وطلب المشورة الطبية على الفور إذا كان لديك أي من الأعراض التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الوجه والشفتين واللسان أو الحلق الذي يسبب صعوبة في البلع أو التنفس.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة شديدة في الجلد (مع كتل مرتفعه).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سرعة&nbsp; أو، عدم انتظام ضربات القلب، والاغماء التي يمكن أن تكون أعراض حالة تهدد حياتكم تعرف باسم تورساد دي بوا .</p><p dir="RTL">إذا لاحظت أي من الأعراض التالية يجب عليك الاتصال بطبيبك على الفور كما حيث الجرعة قد تحتاج إلى خفض أو الايقاف:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بدأت لديك نوبات الصرع لأول مرة أو حدوث نوبات كنت قد تعرضت لها الماضي بشكل متكررا.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغير سلوكك لأنك تشعر بالغبطة أو بالحماسة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تواجه ارتفاع في درجة الحرارة، والإثارة، والارتباك، الارتجاف أو تقلصات العضلات المفاجئة. قد تكون دلائل على وجود حالة نادرة تسمى هذه متلازمة السيروتونين. &nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعب والارتباك وارتعاش العضلات الخاصة بك. قد تكون هذه دلائل على وجود مستوى منخفض من الصوديوم في الدم (نقص صوديوم الدم).</p><p dir="RTL">إذا كان لديك أفكار إيذاء أو قتل نفسك في أي وقت، <strong>اتصل بطبيبك أو اذهب إلى المستشفى على الفور.</strong></p><p dir="RTL">الآثار الجانبية التالية غالبا ما تكون خفيفة وتختفي عادة بعد علاج لبضعة أيام.</p><p dir="RTL">الآثار الجانبية الشائعة جدا (قد يؤثر على أكثر من 1 من كل 10 اشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النعاس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في النوم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في نمط النوم الخاصة بك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان قوة الجسم، والضعف</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة التعرق</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم (جفاف الفم يزيد من خطر تسوس الأسنان، لذا يجب التأكد من تنظيف أسنانك في كثير من الأحيان أكثر من المعتاد)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارجاع (الغثيان)</p><p dir="RTL">الآثار الجانبية الشائعة (قد يؤثر على ما يصل إلى 1 في 10 شخصا)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص الشهية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الانفعال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الدافع الجنسي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلق</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العصبية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتباك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أحلام غير طبيعية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض العواطف، واللامبالاة (اللامبالاة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتعاش</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز أو خدر في اليدين أو القدمين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في التركيز</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع النصفي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الذاكرة (فقدان الذاكرة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرنين في الأذنين (طنين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخفقان</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التثاؤب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد أو سيلان الأنف (التهاب الأنف)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمساك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في المعدة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ البطن (الرياح)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في اللعاب (سيلان اللعاب)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في العضلات والمفاصل</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بالنسبة للرجال، مشاكل القذف والانتصاب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بالنسبة للنساء، فشل في الوصول إلى هزة الجماع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الثقب من الجلد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوزن</p><p dir="RTL">من الاثار الجانبية الغير شائعة (قد يؤثر على ما يصل إلى 1 في كل 100 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التكدم بسهولة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الشهية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العدوان</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهلوسة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هوس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتساع حدقة العين (الجزء المظلم من العين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات القلب السريعة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات القلب البطيئة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح القراص</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشعر</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية لأشعة الشمس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبات التبول</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف الحيض المفرط</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الذراعين أو الساقين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوزن</p><p dir="RTL">من الاثار الجانبية نادرة (قد يؤثر على ما يصل إلى 1 في 1000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الدافع الجنسي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التشنجات</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحركات الغير طوعية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الذوق</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السعال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد الوبائي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء (الضيق)</p><p dir="RTL">وأفادت بعض المرضى (التردد غير معروف)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف مهبلي حاد بعد الولادة (النزيف ما بعد الولادة)، راجع قسم &#39;الحمل والرضاعة والخصوبة&#39; في القسم 2 للمزيد من المعلومات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; افكار إيذاء أو قتل أنفسهم، انظر أيضا القسم 2 &quot;ما تحتاج إلى معرفته قبل اتخاذ لوبرام&quot;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في النزف أو الكدمات الناجمة عن انخفاض في الصفائح الدموية (الصفيحات)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح (فرط الحساسية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات البوتاسيوم في الدم (نقص بوتاسيوم الدم)، الذي يمكن أن يسبب ضعف العضلات، الوخز أو عدم انتظام ضربات القلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في هرمون يسمى البرولاكتين في الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات الذعر</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طحن الأسنان</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأرق</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حركات العضلات غير عادية أو تصلب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حركات لا إرادية في العضلات (تعذر الجلوس)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف الأنفي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات النزيف بما في ذلك الجلد والغشاء المخاطي النزيف (كدمة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم مفاجئ من الجلد أو الغشاء المخاطي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الرجال، انتصاب مؤلم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدفق الحليب من الثدي في الرجال أو النساء الذين ليسوا مرضعين (ثر اللبن)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام فترات الطمث</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف ما بعد الولادة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختبارات وظائف الكبد غير طبيعية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وقد لوحظ زيادة خطر كسور العظام في المرضى الذين يتناولون هذا النوع من الأدوية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضربات القلب الغير طبيعية</p><p dir="RTL">المانع انتقائي لإمتصاص السيروتونين (SSRI) يمكن ، ونادرا جدا، تزيد من خطر النزيف، بما في ذلك المعدة أو النزيف المعوي. أخبر طبيبك إذا كنت تتقيء الدم أو ظهر براز أسود أو ملطخ بالدم.</p><p dir="RTL">اخبر الطبيب ايضا ما إذا كنت لا تزال تواجه الأعراض الأخرى المرتبطة بالاكتئاب الخاص بك. قد تشمل هذه الهلوسة والقلق، الهوس أو الارتباك.</p><p dir="RTL">أي من الآثار الجانبية التي تحدث سوف تختفي عادة بعد بضعة أيام. إذا كانت مزعجة أو مستمرة، أو إذا كنت في وضع أي آثار جانبية غير عادية أخرى بالتزامن مع تناول لوبرام، يرجى إخبار الطبيب بذلك.</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL"><strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&bull; المركز الوطني لمراقبة الأدوية:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال بالهيئة السعودية للغذاء والدواء: 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة &nbsp;أقل من 30 درجة مئوية. بعيدا عن الضوء والرطوبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول الأطفال</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المنصوص عليه في العبوة &nbsp;أو الكرتون. تاريخ انتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تتخلص من أية أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي كيفية رمي الأدوية التي لم تعد تستخدم. سوف تساعد هذه التدابير لحماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي سيتالوبرام (كهيدروبروميد). كل حبة مغلفة بفيلم من لوبرام تحتوي على 20 ملجم سيتالوبرام.</p><p dir="RTL">المكونات الأخرى هي مانيتول، ميكوكريستالين السيلولوز، السيليكا الغروية اللامائية، ستيرات المغنيسيوم، والمياه النقية، هايبروميلوز، ثاني أكسيد التيتانيوم وماكروغول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص 20 ملجم &nbsp;بيضاء إلى ابيض مائل للصفرة ، بيضاوية الشكل ، ثنائية التحدب، مغلفة بفيلم يوجد خط فاصل عميق محفورة على جانب واحد وLM محفورة على الجانب الآخر.</p><p dir="RTL">متوفرة في شريط من الألومنيوم / PVC&nbsp; من 14 قرص. شريطين في كل عبوة كرتونية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشركة العمانية لمستحضرات الصيدلة ش.م.م</p><p dir="RTL">قطعة رقم 108 ، منطقة ريسوت الصناعية ،</p><p dir="RTL">ص.ب: 2240 الرمز البريدي: 211</p><p dir="RTL">صلالة ، سلطنة عمان</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ابريل 2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lopram 20 mg film-coated tablets
Citalopram 20 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 20 mg citalopram (as 24.99 mg Citalopram Hydrobromide).
For a full list of excipients, see 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet. 
20mg tablet. White to off-white, oval shaped, biconvex, film-coated tablets having deep break line engraved on one side and LM monogram engraved on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence.<br />Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology<br />MAJOR DEPRESSIVE EPISODES</strong><br /><u>Adults</u></p><p>Citalopram should be administered as a single oral dose, either in the morning or in the evening.Dependent on individual<br />patient response, the dose may be increased to a maximum of 40 mg daily. In general, improvement in patients starts after one week, but may only become evident from the second week of therapy.</p><p>As with all antidepressant medicinal products, dosage should be reviewed and adjusted, if necessary, within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be an increased potential for undesirable effects at higher doses, if after some weeks on the recommended dose insufficient response is seen, some patients may benefit from having their dose increased up to a maximum of 40 mg a day (see section 5.1).</p><p>Dosage adjustments should be made carefully on an individual patient basis, to maintain the patient at the lowest effective dose.<br />Patients with depression should be treated for a sufficient period of at least 6 months to ensure that&nbsp;they are free from symptoms.</p><p><strong>PANIC DISORDER</strong><br /><u>Adults</u>:<br />A single oral dose of 10 mg is recommended for the first week before increasing the dose to 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily.<br />Patients should be started on 10 mg/day and the dose gradually increased in 10 mg steps according to the patient&#39;s response up to the recommended dose. A low initial starting dose is recommended to minimise the potential worsening of panic symptoms, which is generally recognised to occur early in the treatment of this disorder. Although there may be an increased potential for undesirable effects at higher doses, if after some weeks on the recommended dose insufficient response is seen some patients may benefit from having their dose increased gradually up to a maximum of 40 mg/day (see section 5.1). Dosage adjustments should be made carefully on an individual patient basis, to maintain the patients at the lowest effective dose.<br />Patients with panic disorder should be treated for a sufficient period to ensure that they are free from symptoms. This period may be several months or even longer<br /><u>Elderly patients (&gt;65 years of age)</u><br />For elderly patients the dose should be decreased to half of the recommended dose, e.g. 10-20mg daily. The recommended maximum dose for the elderly is 20mg/daily.<br /><u>Children and adolescents (&lt; 18 years of age)</u><br />Citalopram should not be used in the treatment of children and adolescents under the age of 18 years (see section 4.4).<u>Reduced renal function</u><br />Dosage adjustment is not necessary in cases of mild to moderate renal impairment. No information is available in cases of severe renal impairment (creatinine clearance &lt;20ml/min).</p><p><u>Reduced hepatic function</u><br />An initial dose of 10mg daily for the first two weeks of treatment is recommended in patients with mild or moderate hepatic impairment. Depending on individual patient response, the dose may be increased to a maximum of 20mg daily. Caution and extra careful dose titration is advised in patients with severely reduced hepatic function (see section 5.2).</p><p><u>Poor metabolisers of CYP2C19</u><br />An initial dose of 10 mg daily during the first two weeks of treatment is recommended for patients who are known to be poor metabolisers with respect to CYP2C19. The dose may be increased to a maximum of 20 mg daily depending on individual patient response (see section 5.2).</p><p><strong>Withdrawal symptoms seen on discontinuation of citalopram</strong><br />Abrupt discontinuation should be avoided. When stopping treatment with Citalopram the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see section 4.4 Special Warnings and Precautions for Use and section 4.8 Undesirable Effects). If intolerable symptoms occur following a decrease in the dose upon<br />discontinuation of treatment, then resuming the previously prescribed dose may be considered. Subsequently, the physician may continue decreasing the dose, but at a more gradual rate.</p><p><strong>Method of administration</strong><br />Citalopram tablets are administered as a single daily dose. Citalopram tablets can be taken at any&nbsp;time of the day without regard to food intake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to citalopram or to any of the excipients. (See section 6.1)
Monoamine Oxidase Inhibitors (MAOIs)
Some cases presented with features resembling serotonin syndrome.
Citalopram should not be given to patients receiving Monoamine Oxidase Inhibitors (MAOIs) including selegiline in daily doses exceeding 10mg/day. 
Citalopram should not be given for fourteen days after discontinuation of an irreversible MAOI or for the time specified after discontinuation of a reversible MAOI (RIMA) as stated in the prescribing text of the RIMA. 
MAOIs should not be introduced for seven days after discontinuation of citalopram (see section 4.5).
Citalopram is contraindicated in the combination with linezolid unless there are facilities for close observation and monitoring of blood pressure (see section 4.5).
Concomitant treatment with pimozide (see also section 4.5)
Citalopram is contraindicated in patients with known QT-interval prolongation or congenital long QT syndrome.
Citalopram is contraindicated together with medicinal products that are known to prolong the QT-interval (see section 4.5).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Suicide/suicidal thoughts or clinical worsening</u></p><p style="text-align:justify">Depression is associated with an increased risk of suicidal thoughts, self harm and suicide (suicide-related events). This risk persists until significant remission occurs. As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored until such improvement occurs. It is general clinical experience that the risk of suicide may increase in the early stages of recovery.</p><p style="text-align:justify">Other psychiatric conditions for which citalopram are prescribed can also be associated with an increased risk of suicide-related events. In addition, these conditions may be co-morbid with major depressive disorder. The same precautions observed when treating patients with major depressive disorder should therefore be observed when treating patients with other psychiatric disorders.</p><p style="text-align:justify">Patients with a history of suicide-related events, or those exhibiting a significant degree of suicidal ideation prior to commencement of treatment are known to be at greater risk of suicidal thoughts or suicide attempts, and should receive careful monitoring during treatment. A meta- analysis of placebo-controlled clinical trials of antidepressant drugs in adult patients with psychiatric disorders showed an increased risk of suicidal behaviour with antidepressants compared to placebo in patients less than 25 years old.</p><p style="text-align:justify">Close supervision of patients and in particular those at high risk should accompany drug therapy especially in early treatment and following dose changes. Patients (and caregivers of patients) should be alerted about the need to monitor for any clinical worsening, suicidal behaviour or thoughts and unusual changes in behaviour and to seek medical advice immediately if these symptoms present.</p><p style="text-align:justify"><u>Use in children and adolescents under 18 years of age</u><br />Citalopram should not be used in the treatment of children and adolescents under the age of 18 years. Suicide-related behaviours (suicide attempt and suicidal thoughts) and hostility (predominantly aggression, oppositional behaviour and anger) were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo. If, based on clinical need, a decision to treat is nevertheless taken; the patient should be carefully monitored for the appearance of suicidal symptoms.<br />In addition, long-term safety data in children and adolescents concerning growth, maturation and cognitive and behavioural development are lacking.</p><p style="text-align:justify"><u>Elderly patients</u><br />Caution should be used in the treatment of elderly patients (see section 4.2).</p><p style="text-align:justify"><u>Reduced kidney and liver function</u><br />Caution should be used in the treatment of patients with reduced kidney and liver function (see section 4.2).</p><p style="text-align:justify"><u>Paradoxical anxiety:</u></p><p style="text-align:justify">Some patients with panic disorder may experience intensified anxiety symptoms at the start of treatment with antidepressants. This paradoxical reaction usually subsides within the first two weeks of starting treatment. A low starting dose is advised to reduce the likelihood of a paradoxical anxiogenic effect (see section 4.2).</p><p style="text-align:justify"><u>Akathisia/psychomotor restlessness</u></p><p style="text-align:justify">The use of citalopram has been associated with the development of akathisia, characterised by a subjectively unpleasant or distressing restlessness and need to move often accompanied by an inability to sit or stand still. This is most likely to occur within the first few weeks of treatment. In patients who develop these symptoms, increasing the dose may be detrimental.</p><p style="text-align:justify"><u>Mania</u></p><p style="text-align:justify">Citalopram should be used with caution in patients with a history of manic/hypomanic- depressive illness as a change towards the manic phase may occur. Citalopram should be discontinued in any patient entering a manic phase.</p><p style="text-align:justify"><u>Seizures</u></p><p style="text-align:justify">Seizures are a potential risk with antidepressant drugs. Citalopram should be discontinued in any patient who develops seizures. Citalopram should be avoided in patients with unstable epilepsy and patients with controlled epilepsy should be carefully monitored. Citalopram should be discontinued if there is an increase in seizure frequency.</p><p style="text-align:justify"><u>Diabetes</u></p><p style="text-align:justify">In patients with diabetes, treatment with an SSRI may alter glycaemic control. Insulin and/or oral hypoglycaemic dosage may need to be adjusted.</p><p style="text-align:justify">Angle-closure Glaucoma<br />SSRIs including citalopram may have an effect on pupil size resulting in mydriasis. This mydriatic effect has the potential to narrow the eye angle resulting in increased intraocular pressure and angle-closure glaucoma, especially in patients pre-disposed. Citalopram should therefore be used with caution in patients with angle-closure glaucoma or history of glaucoma</p><p><u>Serotonin syndrome</u></p><p>In rare cases, serotonin syndrome, a potential life-threatening condition, has been reported in patients using SSRIs (see section 4.5).</p><p>If concomitant treatment with other serotonergic agents is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases.</p><p>Symptoms of serotonin syndrome may include mental-status changes, autonomic instability, neuromuscular abnormalities, and/or gastrointestinal symptoms. If serotonin syndrome is suspected, treatment with citalopram should be discontinued immediately and symptomatic treatment initiated.</p><p><u>Serotonergic medicines</u></p><p>Citalopram should not be used concomitantly with medicinal products with serotonergic effects such as triptans (including sumatriptan and oxitriptan) opioids (including tramadol and buprenorphine) and tryptophan due to risk of serotonin syndrome</p><p style="text-align:justify"><u>Haemorrhage</u><br />There have been reports of prolonged bleeding time and/or bleeding abnormalities such as ecchymoses, gynaecological haemorrhages, gastrointestinal bleedings and other cutaneous or mucous bleedings with SSRIs (see section 4.8). SSRIs/SNRIs may increase the risk of postpartum hemorrhage. Caution is advised in patients taking SSRIs, particularly in concomitant use with active substances known to affect platelet function or other active substances that can increase the risk of haemorrhage as well as in patients with a history of bleeding disorders (see section 4.5).</p><p style="text-align:justify"><u>Electroconvulsive Therapy (ECT)</u><br />There is limited clinical experience of concurrent administration of SSRIs and electroconvulsive therapy, therefore caution is advisable.</p><p style="text-align:justify"><u>Reversible, selective MAO-A inhibitors</u></p><p style="text-align:justify">For information on concomitant treatment with non-selective, irreversible MAO-inhibitors see section 4.5.</p><p style="text-align:justify"><u>St John&#39;s wort (Hypericum perforatum)</u></p><p style="text-align:justify">Undesirable effects may be more common during concomitant use of citalopram and herbal preparations containing St John&#39;s wort (Hypericum perforatum). Therefore citalopram and St John&#39;s wort preparations should not be taken concomitantly (see section 4.5).</p><p style="text-align:justify"><u>Withdrawal symptoms seen on discontinuation of SSRI treatment</u><br />Withdrawal symptoms when treatment is discontinued are common, particularly if discontinuation is abrupt (see section 4.8 Undesirable effects). In a recurrence prevention clinical trial with citalopram, adverse events after discontinuation of active treatment were seen in 40% of patients versus 20% in patients continuing citalopram.<br />The risk of withdrawal symptoms may be dependent on several factors including the duration and dose of therapy and the rate of dose reduction. Dizziness, sensory disturbances (including paraesthesia, sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/or vomiting, tremor, confusion, sweating, headache, diarrhoea, palpitations, emotional instability, irritability and visual disturbances are the most commonly reported reactions.<br />Generally these symptoms are mild to moderate; however, in some patients they may be severe in intensity. They usually occur within the first few days of discontinuing treatment, but there have been very rare reports of such symptoms in patients who have inadvertently missed a dose. Generally these symptoms are self-limiting and usually resolve within 2 weeks, though in some individuals they may be prolonged (2-3 months or more). It is therefore advised that Citalopram should be gradually tapered when discontinuing treatment over a period of several weeks or months, according to the patient&#39;s needs (see &quot;Withdrawal Symptoms Seen on Discontinuation&quot;, section 4.2).&rdquo;</p><p style="text-align:justify"><u>Sexual dysfunction</u><br />Selective serotonin reuptake inhibitors (SSRIs/serotonin norepinephrine reuptake inhibitors (SNRIs) may cause symptoms of sexual dysfunction (see section 4.8). There have been reports of long-lasting sexual dysfunction where the symptoms have continued despite discontinuation of SSRIs/SNRI.</p><p style="text-align:justify"><u>Psychosis</u><br />Treatment of psychotic patients with depressive episodes may increase psychotic symptoms.</p><p style="text-align:justify"><u>QT interval prolongation</u><br />Citalopram has been found to cause a dose-dependent prolongation of the QT-interval. Cases of QT interval prolongation and ventricular arrhythmia including torsade de pointes have been reported during the post-marketing period, predominantly in patients of female gender, with hypokalemia, or with pre-existing QT prolongation or other cardiac diseases (see sections 4.3, 4.5, 4.8, 4.9 and 5.1).<br />Caution is advised in patients with significant bradycardia; or in patients with recent acute myocardial infarction or uncompensated heart failure.<br />Electrolyte disturbances such as hypokalaemia and hypomagnesaemia increase the risk for malignant arrhythmias and should be corrected before treatment with citalopram is started.<br />If patients with stable cardiac disease are treated, an ECG review should be considered before treatment is started.<br />ECG monitoring may be advisable in case of overdose or conditions of altered metabolism with increased peak levels, e.g. liver impairment.<br />If signs of cardiac arrhythmia occur during treatment with citalopram, the treatment should be withdrawn and an ECG should be performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pharmacodynamic interactions</u></p><p>At the Pharmacodynamic level cases of serotonin syndrome with citalopram and moclobemide and buspirone have been reported.</p><p><u>Contraindicated combinations:</u></p><p><em>Strong and moderate inhibitors of CYP2C19</em></p><p>Strong and moderate inhibitors of CYP2C19 may result in increased exposure to N-desmethylclobazam, the active metabolite of clobazam. This may increase the risk of dose related adverse reaction.</p><p>MAO-inhibitors</p><p>The simultaneous use of citalopram and MAO-inhibitors can result in severe side effects, including the serotonin syndrome (see section 4.3).</p><p>Cases of serious and sometimes fatal reactions have been reported in patients receiving an SSRI in combination with a monoamine oxidase inhibitor (MAOI), including the irreversible MAOI selegiline and the reversible MAOIs linezolid and moclobemide and in patients who have recently discontinued an SSRI and have been started on a MAOI.</p><p>Some cases presented with features resembling serotonin syndrome. Symptoms of an active substance interaction with a MAOI include: agitation, tremor, myoclonus and hyperthermia.</p><p><em>QT interval prolongation</em></p><p>Pharmacokinetic and pharmacodynamic studies between citalopram and other medicinal products that prolong the QT interval have not been performed. An additive effect of citalopram and these medicinal products cannot be excluded. Therefore, co-administration of citalopram with medicinal products that prolong the QT interval, such as Class IA and III antiarrhythmics, antipsycotics (e.g. fentiazine derviatives, pimozide, haloperidol), tricyclic antidepressants , certain antimicrobial agents (e.g. sparfloxacin, moxifloxacin, erythromycin IV, pentamidine, anti-malarian&nbsp;&nbsp;&nbsp;&nbsp; treatment&nbsp;&nbsp;&nbsp; particularly&nbsp;&nbsp;&nbsp;&nbsp; halofantrine),&nbsp;&nbsp;&nbsp;&nbsp; certain&nbsp;&nbsp;&nbsp;&nbsp; antihistamines&nbsp;&nbsp;&nbsp;&nbsp; (astemizole, mizolastine) etc., is contraindicated.</p><p>Pimozide<br />Co-administration of a single dose of pimozide 2 mg to subjects treated with racemic citalopram 40 mg/day for 11 days caused an increase in AUC and Cmax of pimozide, although not consistently throughout the study. The co-administration of pimozide and citalopram resulted in a mean increase in the QTc interval of approximately 10 msec. Due to the interaction noted at a low dose of pimozide, concomitant administration of citalopram and pimozide is contraindicated.</p><p><em><u>Combinations requiring precaution for use</u></em></p><p>Selegiline (selective MAO-B inhibitor)</p><p>A pharmacokinetic/pharmacodynamic interaction study with concomitantly administered citalopram (20mg daily) and selegiline (10mg daily) (a selective MAO-B inhibitor) demonstrated no clinically relevant interactions. The concomitant use of citalopram and selegiline (in doses above 10mg daily) is not recommended.</p><p><em>Serotonergic medicinal products:</em></p><p>Lithium and tryptophan</p><p>No pharmacodynamic interactions have been found in clinical studies in which citalopram has been given concomitantly with lithium. However, there have been reports of enhanced effects when SSRIs have been given with lithium or tryptophan and therefore the concomitant use of citalopram with these medicinal products should be undertaken with caution. Routine monitoring of lithium levels should be continued as usual.</p><p>Co-administration with serotonergic medicinal products e.g. opioids (including tramadol and buprenorphine) and triptans (including sumatriptan and oxitriptan) may lead to an increased risk of serotonin syndrome, a potential life-threatening condition (see section 4.4).</p><p><em>St John&#39;s Wort</em></p><p>Dynamic interactions between SSRIs and the herbal remedy St John&#39;s wort (Hypericum perforatum) can occur, resulting in an increase in undesirable effects (see section 4.4). Pharmacokinetic interactions have not been investigated.</p><p><em>Haemorrhage</em><br />Caution is warranted for patients who are being treated simultaneously with anticoagulants, medicines that affect the function of thrombocytes, such as non steroidal anti-inflammatory drugs (NSAIDs), acetylsalicylic acid, dipyridamole, and ticlopidine or other medicines (e.g. atypical antipsychotics, phenothiazines, tricyclic depressants) that can increase the risk of haemorrhage (see section 4.4).</p><p><em>ECT (electroconvusive therapy)</em></p><p>There are no clinical studies establishing the risks or benefits of the combined use of electroconvulsive therapy (ECT) and citalopram (see section 4.4).</p><p><em>Alcohol</em></p><p>No pharmacodynamic or pharmacokinetic interactions have been demonstrated between citalopram and alcohol. However, the combination of citalopram and alcohol is not advisable.</p><p><em>Medicinal products including QT prolongation or hypokalaemia/hypomagnesaemia</em></p><p>Caution is warranted for concomitant use of other QT interval prolonging medicines or hypokalaemia/hypomagnesaemia inducing drugs as they, like Citalopram, also prolong the QT interval.</p><p><em>Medicinal products lowering the seizure threshold</em></p><p>SSRIs can lower the seizure threshold. Caution is advised when concomitantly using other medicinal products capable of lowering the seizure threshold (e.g. antidepressants (tricyclics, SSRIs), neuroleptics (phenothiazines, thioxanthenes and butyrophenones), mefloquin, bupropion and tramadol).</p><p><u>Pharmacokinetic interactions</u></p><p>Biotransformation of citalopram to demethylcitalopram is mediated by CYP2C19 (approx. 38%), CYP3A4 (approx. 31%) and CYP2D6 (approx. 31%) isoenzymes of the cytochrome P450 system. The fact that citalopram is metabolised by more than one CYP means that inhibition of its biotransformation is less likely as inhibition of one enzyme may be compensated by another. Therefore co-administration of citalopram with other medicinal products in clinical practice has very low likelihood of producing pharmacokinetic medicinal product interactions.</p><p><em>Food</em><br />The absorption and other pharmacokinetic properties of citalopram have not been reported to be affected by food.</p><p><u>Effect of other medicinal products on the pharmacokinetics of citalopram</u></p><p>Co-administration with ketoconazole (potent CYP3A4 inhibitor) did not change the pharmacokinetics of citalopram.<br />A pharmacokinetic interaction study of lithium and citalopram did not reveal any pharmacokinetic interactions (see also above).</p><p><u>Cimetidine</u></p><p>Cimetidine (potent CYP2D6, 3A4 and 1A2 inhibitor) caused a moderate increase in the average steady-state levels of citalopram. Caution is advised when administering citalopram in combination with cimetidine. Dose adjustment may be warranted.</p><p>Co-administration of excitalopram (the active enantiomer of citalopram) with omeprazole 30mg once daily (a CYP2C19 inhibitor) resulted in moderate (approximately 50%) increase in the plasma concentrations of escitalopram.</p><p>Thus, caution should be exercised when used concomitantly with CYP2C19 inhibitors (e.g. omeprazole, esomeprazole, fluvoxamine, lansoprazole, ticlopidine) or cimetidine. A reduction in the dose of citalopram may be necessary based on monitoring of undesirable effects during concomitant treatment.</p><p><u>Metoprolol</u><br />Escitalopram (the active enantiomer of citalopram) is an inhibitor of the enzyme CYP2D6. Caution is recommended when citalopram is co-administered with medicinal products that are mainly metabolised by this enzyme, and that have a narrow therapeutic index, e.g. flecainide, propafenone and metoprolol (when used in cardiac failure), or some CNS acting medicinal products that are mainly metabolised by CYP2D6, e.g. antidepressants such as desipramine, clomipramine and nortriptyline or antipsychotics like risperidone, thioridazine and haloperidol.<br />Dosage adjustment may be warranted. Co-administration with metoprolol resulted in a twofold increase in the plasma levels of metoprolol, but did not statistically significant increase the effect of metoprolol on the blood pressure and cardiac rhythm.</p><p><em><u>Effects of citalopram on other medicinal products</u></em></p><p>A pharmacokinetic/pharmacodynamic interaction study with concomitant administration of citalopram and metoprolol (a CYP2D6 substrate) showed a twofold increase in metoprolol concentrations, but no statistically significant increase in the effect of metoprolol on blood pressure and heart rate in healthy volunteers.</p><p>Citalopram and demethylcitalopram are negligible inhibitors of CYP2C9, CYP2E1 and CYP3A4, and only weak inhibitors of CYP1A2, CYP2C19 and CYP2D6 as compared to other SSRIs established as significant inhibitors.</p><p><em>Levomepromazine, digoxin, carbamazepine</em></p><p>No change or only very small changes of no clinical importance were observed when citalopram was given with CYP1A2 substrates (clozapine and theophylline), CYP2C9 (warfarin), CYP2C19 (imipramine and mephenytoin), CYP2D6 (sparteine, imipramine, amitriptyline, risperidone) and CYP3A4 (warfarin, carbamazepine (and its metabolite carbamazepine epoxid) and triazolam.</p><p>No pharmacokinetic interaction was observed between citalopram and levomepromazine or digoxin (indicating that citalopram neither induces nor inhibits P-glycoprotein).</p><p><em>Desipramine, imipramine</em><br />In a pharmacokinetic study no effect was demonstrated on either citalopram or imipramine levels, although the level of desipramine, the primary metabolite of imipramine was increased. When desipramine is combined with citalopram, an increase of the desipramine plasma concentration has been observed. A reduction of the desipramine dose may be needed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Published data&nbsp;on pregnant women (more than 2500 exposed outcomes) indicates no malformative feto/ neonatal toxicity, however Citalopram should not be used during pregnancy unless clearly necessary and only after careful consideration of risk/benefit.</p><p>Neonates should be observed if maternal use of Citalopram continues into the later stages of pregnancy, particular in the third trimester. Abrupt discontinuation should be avoided during pregnancy.</p><p>The following symptoms may occur in the neonate after maternal SSRI/SNRI use in later stages of pregnancy: respiratory distress, cyanosis, apnoea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycaemia, hypertonia, hypotonia, hyperreflexia, tremor, jitteriness, irritability, lethargy, constant crying, somnolence and difficulty sleeping. These symptoms could be due to either serotonergic effects or withdrawal symptoms. In a majority of instances the complications begin immediately or soon (&lt; 24 hours) after delivery.</p><p>Epidemiological data have suggested that the use of SSRIs in pregnancy, particular in late pregnancy, may increase the risk of persistent pulmonary hypertension in the newborn (PPHN). The observed risk was approximately 5 cases per 1000 pregnancies. In the general population 1 to 2 cases of PPHN per 1000 pregnancies occur.</p><p>Studies in animals have shown reproductive toxicity (see section 5.3).</p><p><br />Observational data indicate an increased risk (less than 2-fold) of postpartum hemorrhage following SSRI/SNRI exposure within the month prior to birth.</p><p><u>Breast-feeding:</u></p><p>Citalopram is excreted into breast milk. It is estimated that the suckling infant will receive about 5% of the weight related maternal daily dose (in mg/kg). No or only minor events have been observed in the infants. However, the existing information is insufficient for assessment of the risk to the child. Caution is recommended.</p><p>Caution is recommended. If treatment with citalopram is considered necessary, discontinuation of breast feeding should be considered.</p><p><u>Fertility:</u></p><p>Animal data have shown that citalopram may affect sperm quality (see section 5.3).</p><p>Human case reports with some SSRIs have shown that an effect on sperm quality is reversible. Impact on human fertility has not been observed so far.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Citalopram has minor or moderate influence on the ability to drive and use machines.</p><p>Patients who are prescribed psychotropic medication may be expected to have some impairment of general attention and concentration due to the illness itself and psychoactive medicinal products can reduce the ability to make judgements and to react to emergencies. Patients should be informed of these effects and be warned that their ability to drive a car or operate machinery could be affected.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse effects observed with citalopram are in general mild and transient. They are most frequent during the first one or two weeks of treatment and usually attenuate subsequently. The adverse reactions are presented at the MedDRA Preferred Term Level.</p><p>For the following reactions a dose-response was discovered: Sweating increased, dry mouth, insomnia, somnolence, diarrhoea, nausea and fatigue.</p><p>The table shows the percentage of adverse drug reactions associated with SSRIs and/or citalopram seen in either &ge; 1% of patients in double-blind placebo-controlled trials or in the post- marketing period. Frequencies are defined as: very common (&ge;1/10); common (&ge;1/100, &lt;1/10); uncommon (&ge;1/1000, &le;1/100); rare (&ge;1/10000, &le;1/1000); very rare (&le;1/10000), not known (can not be estimated from available data).</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top; width:274px"><p><strong>System organ class</strong></p></td><td style="vertical-align:top; width:76px"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable effect</strong></p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Blood and lymphatic disorders</p></td><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Thrombocytopenia</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Immune system disorders</p></td><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Hypersensitivity , anaphylactic reaction</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Endocrine disorders</p></td><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Inappropriate ADH secretion</p></td></tr><tr><td rowspan="4" style="vertical-align:top; width:274px"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Appetite decreased,&nbsp;weight decreased</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Increased appetite, weight increased</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Rare</p></td><td style="vertical-align:top"><p>Hyponatremia</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Hypokalaemia</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Psychiatric disorders</p></td><td style="vertical-align:top; width:76px"><p>Very common</p></td><td style="vertical-align:top"><p>Sleep disorder</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:274px"><p>&nbsp;</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Agitation, libido decreased, anxiety, nervousness, confusional state, abnormal orgasm (female), abnormal dreams,&nbsp;apathy</p></td></tr><tr><td style="vertical-align:top; width:76px">&nbsp; &nbsp; Uncommon</td><td style="vertical-align:top">&nbsp; &nbsp; Aggression, depersonalization, hallucination, mania,&nbsp;libido increased</td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Panic attack, bruxism, restlessness, suicidal ideation, suicidal behaviour<sup>1</sup></p></td></tr><tr><td rowspan="5" style="vertical-align:top; width:274px"><p>Nervous system disorders</p></td><td style="vertical-align:top; width:76px"><p>Very common</p></td><td style="vertical-align:top"><p>Somnolence, insomnia,&nbsp;headache</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Tremor, paraesthesia, dizziness, disturbance in attention, migraine, amnesia migraine, amnesia, migraine, amnesia</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Syncope</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Rare</p></td><td style="vertical-align:top"><p>Convulsion grand mal, dyskinesia, taste disturbance</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Convulsions , serotonin syndrome, extrapyramidal disorder, akathisia, movement disorder</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:274px"><p>Eye disorders</p></td><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Mydriasis&nbsp;(which may lead to acute narrow angle glaucoma), see section 4.4 Special<br />warnings and precautions for use</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Visual disturbance</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Tinnitus</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:274px"><p>Cardiac disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Palpitations</p></td></tr><tr><td style="vertical-align:top; width:76px">&nbsp; &nbsp; Uncommon</td><td style="vertical-align:top">&nbsp; &nbsp; Bradycardia, tachycardia</td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>QT-prolongation,&nbsp;ventricular arrhythmia including torsade de pointes</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:274px"><p>Vascular disorders</p></td><td style="vertical-align:top; width:76px"><p>Rare</p></td><td style="vertical-align:top"><p>Haemorrhage</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Orthostatic hypotension</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:274px"><p>Respiratory thoracic and mediastinal disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Yawning,&nbsp;rhinitis</p></td></tr><tr><td style="vertical-align:top; width:76px">&nbsp; &nbsp; Rare</td><td style="vertical-align:top">&nbsp; &nbsp;&nbsp;Coughing</td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Epistaxis</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:274px"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top; width:76px"><p>Very common</p></td><td style="vertical-align:top"><p>Dry mouth, Nausea</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Diarrhoea vomiting, Constipation, dyspepsia, abdominal pain, flatulence, salivary<br />hypersecretion</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Gastrointestinal haemorrhage (including rectal haemorrhage)</p></td></tr><tr><td rowspan="2" colspan="1" style="vertical-align:top; width:274px"><p>Hepatobiliary disorders</p><p>&nbsp;</p></td><td style="vertical-align:top; width:76px"><p>Rare</p></td><td style="vertical-align:top"><p>Hepatitis</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Liver function test abnormal</p></td></tr><tr><td rowspan="4" style="vertical-align:top; width:274px"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top; width:76px"><p>Very common</p></td><td style="vertical-align:top"><p>Sweating increased</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Pruritus</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Urticaria, alopecia, rash, purpura, photosensitivity reaction</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Ecchymosis, angioedemas</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Musculoskeletal, connective tissue and bone disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Myalgia, arthralgia</p></td></tr><tr><td style="vertical-align:top; width:274px"><p>Renal and urinary disorders</p></td><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Urinary retention</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:274px"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top; width:76px"><p>Common</p></td><td style="vertical-align:top"><p>Impotence, ejaculation disorder, ejaculation failure</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Female: Menorrhagia</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Not Known</p></td><td style="vertical-align:top"><p>Female: Metrorrhagia,&nbsp;postpartum haemorrhage<sup>2</sup></p><p>Male: Priapism, galactorrhoea</p></td></tr><tr><td rowspan="4" style="vertical-align:top; width:274px"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top; width:76px"><p>Very common</p></td><td style="vertical-align:top"><p>Asthenia</p></td></tr><tr><td style="vertical-align:top; width:76px">&nbsp; &nbsp; Common</td><td style="vertical-align:top">&nbsp; &nbsp;Fatigue</td></tr><tr><td style="vertical-align:top; width:76px"><p>Uncommon</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr><tr><td style="vertical-align:top; width:76px"><p>Rare</p></td><td style="vertical-align:top"><p>Pyrexia, malaise</p></td></tr></tbody></table><p>Number of patients: Citalopram / placebo = 1346 / 545</p><p>1Cases of suicidal ideation and suicidal behaviours have been reported during citalopram therapy or early after treatment discontinuation (see section 4.4).</p><p>2 This event has been reported for the therapeutic class of SSRIs/SNRIs (see sections 4.4, 4.6 and 5.1).</p><p>Cases of QT-prolongation and ventricular arrhythmia including torsade de pointes have been reported during the post-marketing period, predominantly in patients of female gender, with hypokalemia, or with pre-existing QT prolongation or other cardiac diseases (see sections 4.3, 4.4, 4.5, 4.9 and 5.1).</p><p><em><u>Class effects</u></em></p><p>Epidemiological studies, mainly conducted in patients 50 years of age and older, show an increased risk of bone fractures in patients receiving SSRIs and TCAs. The mechanism leading to this risk is unknown.</p><p><u>Withdrawal symptoms seen on discontinuation of SSRI treatment: </u></p><p>Discontinuation of citalopram (particularly when abrupt) commonly leads to withdrawal symptoms. Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), agitation or anxiety, nausea and/or vomiting, tremor confusion, sweating, headache, diarrhoea, palpitations, emotional instability, irritability, and visual disturbances are the most commonly reported reactions. Generally these events are mild to moderate and are self-limiting, however, in some patients they may be severe and/or prolonged. It is therefore advised that when citalopram treatment is no longer required, gradual discontinuation by dose tapering should be carried out (see section 4.2 and section 4.4).</p><p>To report any side effect(s):<br />Saudi Arabia:</p><p>&bull; The National Pharmacovigilance Centre (NPC):<br />- Fax: +966-11-205-7662<br />- Call NPC at +966-11-2038222, Ext 2317-2356-2340<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa/</p><p>Other GCC States:</p><p>Ministry of Health, Oman:<br />Department of Pharmacovigilance &amp; Drug Information<br />Directorate General of Pharmaceutical Affairs &amp; Drug Control, Ministry of Health<br />P.O.BOX: 393, Muscat, PC: 100, Sultanate of Oman<br />Phone: 22357688/ 22357687/ 22357686 Fax: 22358489;<br />Email: pharma-vigil@moh.gov.om</p><p>Ministry of Health, UAE:<br />Pharmacovigilance &amp; Medical Device section<br />Ministry of Health &amp; Prevention<br />Dubai, UAE</p><p>Jordan Food and Drug Administration (JFDA):<br />P.O.Box7704, Amman 11118, Jordan<br />(www.jfda.jo) or E-mail: jpc@jfda.jo</p><p>Ministry of Health Kuwait, Drug and Food Control:<br />(www.moh.gov.kw/kdfc)<br />Supreme council of health, pharmacy &amp; drug control<br /><br />Ministry of Public Health, State of Qatar:<br />Pharmacy &amp; Drug Control Department<br />Web:https://www.moph.gov.qa/health-services/Pages/pharmacy-n-drug-control.aspx</p><p>MAH &amp; Manufacturer:<br />Oman Pharmaceutical products Co. LLC.<br />reg@omanpharma.com and pv@omanpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Toxicity</u></p><p>Comprehensive clinical data on citalopram overdose are limited and many cases involve concomitant overdoses of other drugs/alcohol. Fatal cases of citalopram overdose have been reported with citalopram alone; however, the majority of fatal cases have involved overdose with concomitant medications.</p><p>Fatal dose is not known. Patients have survived ingestion of more than 2 g citalopram.</p><p>The effects may be potentiated by alcohol taken at the same time.<br />Potential interaction with TCAs, MAOIs and other SSRIs.</p><p><u>Symptoms</u></p><p>The following symptoms have been seen in reported overdose of citalopram: convulsion, tachycardia, somnolence, QT prolongation, coma, vomiting, tremor, hypotension, cardiac arrest, nausea, serotonin syndrome, agitation, bradycardia, dizziness, bundle branch block, QRS prolongation, hypertension, mydriasis, torsade de pointes, stupor, sweating, cyanosis, hyperventilation, and atrial and ventricular arrythmia.</p><p>ECG changes including nodal rhythm, prolonged QT intervals and wide QRS complexes may occur. Fatalities have been reported.<br />Prolonged bradycardia with severe hypotension and syncope has also been reported.<br />Rarely, features of the &quot;serotonin syndrome&quot; may occur in severe poisoning. This includes alteration of mental status, neuromuscular hyperactivity and autonomic instability. There may be hyperpyrexia and elevation of serum creatine kinase. Rhabdomyolysis is rare.</p><p><u>Treatment</u></p><p>There is no known specific antidote to citalopram. Treatment should be symptomatic and supportive&nbsp;and include the maintenance of a clear airway<br />and monitoring of ECG and vital signs until stable. ECG monitoring is advisable in case of overdose in patients with congestive heart failure/bradyarrhythmias, in patients using concomitant medications that prolong the QT interval, or in patients with altered metabolism, e.g. liver<br />impairment.</p><p>Consider oral activated charcoal in adults and children who have ingested more than 5 mg/kg body weight within 1 hour.<br />Activated charcoal given &frac12; hour after ingestion of citalopram has been shown to reduce absorption by 50%.<br />Osmotically working laxative (such as sodium sulphate) and stomach evacuation should be considered.<br />If consciousness is impaired the patient should be intubated.</p><p>Control convulsions with intravenous diazepam if they are frequent or prolonged.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pharmacotherapeutic group: antidepressants, selective serotonin reuptake inhibitors</u><br /><u>ATC code</u>: N06A B04<br /><u>Mechanism of action</u><br />Biochemical and behavioural studies have shown that citalopram is a potent inhibitor of the serotonin (5-HT)-uptake. Tolerance to the inhibition of 5-HT-uptake is not induced by long-term treatment with citalopram.</p><p>Citalopram is a very Selective Serotonin Reuptake Inhibitor (SSRI), with no, or minimal, effect on noradrenaline (NA), dopamine (DA) and gamma aminobutyric acid (GABA) uptake.<br />In contrast to many tricyclic antidepressants and some of the newer SSRIs, citalopram has no or very low affinity for a series of receptors including 5-HT 1A, 5-HT2, DA D1 and D2 receptors, &alpha;1-, &alpha;2-, &beta;-adrenoceptors, histamine H1, muscarine cholinergic, benzodiazepine, and opioid receptors. A series of functional in vitro tests in isolated organs as well as functional in vivo tests have confirmed the lack of receptor affinity.<br />This absence of effects on receptors could explain why citalopram produces fewer of the traditional side effects such as dry mouth, bladder and gut disturbance, blurred vision, sedation, cardiotoxicity and orthostatic hypotension.<br />The main metabolites of citalopram are all SSRIs although their potency and selectivity ratios are lower than those of citalopram. However, the selectivity ratios of the metabolites are higher than those of many of the newer SSRIs. The metabolites do not contribute to the overall antidepressant<br />effect.</p><p>Pharmacodynamic effects<br />Suppression of rapid eye movement (REM) sleep is considered a predictor of antidepressant activity. Like tricyclic antidepressants, other SSRIs and MAO inhibitors, citalopram suppresses REM-sleep and increases deep slow-wave sleep.</p><p>Although citalopram does not bind to opioid receptors it potentiates the anti-nociceptive effect of commonly used opioid analgesics. There was potentiation of d-amphetamine-induced hyperactivity following administration of citalopram.<br />In humans citalopram does not impair cognitive (intellectual function) and psychomotor performance and has no or minimal sedative properties, either alone or in combination with alcohol.<br />Citalopram has almost no effect on the neuronal uptake of noradrenaline, dopamine and gammaaminobutyric acid. Citalopram shows no affinity, or only very little, for cholinergic, histaminergic and a variety of adrenergic, serotonergic and dopaminergic receptors.<br />Citalopram did not reduce saliva flow in a single dose study in human volunteers and in none of the studies in healthy volunteers did citalopram have significant influence on cardiovascular parameters. Citalopram has no effect on the serum levels of prolactin and growth hormone.<br />In a double-blind, placebo-controlled ECG study in healthy subjects, the change from baseline in QTc (Fridericia-correction) was 7.5 (90%CI 5.9-9.1) msec at the 20 mg/day dose and 16.7 (90%CI 15.0-18.4) msec at the 60 mg day/dose (see sections 4.3, 4.4, 4.5, 4.8 and 4.9).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption</em><br />Absorption is almost complete and independent of food intake (Tmax average/mean 3.8 hours).Oral bioavailability is approximately 80%..</p><p><em>Distribution:</em></p><p>The apparent volume of distribution (Vd)&beta; is about 12.3 L/kg. The plasma protein binding is below 80% for citalopram and its main metabolites.</p><p><em>Bio-transformation:</em></p><p>Citalopram is metabolised into demethylcitalopram, didemethylcitalopram, citalopram-N-oxide and the deaminated propionic acid-derivative. All the active metabolites are also SSRIs, although weaker than the parent compound. Unchanged citalopram is the predominant compound in<br />plasma.</p><p><em>Elimination:</em></p><p>The elimination half-life is (T&frac12;&beta;) is about 1.5 days and systemic plasma clearance (Cls) is 0.33 L/min and oral plasma clearance (Cl oral) is approximately 0.41 L/min.<br />Citalopram is mainly eliminated via the liver (85%), but the remainder (15%) via the kidneys. About 12% of the daily dose is excreted in urine as unchanged citalopram. Hepatic (residual) clearance is about 0.35 L/min and renal clearance is 0.068 L/min.<br />The kinetics are linear. Steady-state plasma levels are achieved in 1-2 weeks. verage concentrations of 250 nmol/L (100-500 nmol/L) are achieved at a daily dose of 40 mg. There is no clear relationship between citalopram plasma levels and therapeutic response or side effects</p><p><em>Elderly patients&nbsp;(&ge; 65 years)</em></p><p>Longer half-lives and decreased clearance values due to a reduced rate of metabolism have been demonstrated in elderly patients..</p><p><em>Reduced hepatic function</em></p><p>Citalopram is eliminated more slowly in patients with reduced hepatic function. The half-life of citalopram is about twice as long and steady state citalopram concentrations at a given dose will be about twice as high as in patients with normal liver function..</p><p><em>Reduced renal function</em></p><p>Citalopram is eliminated more slowly in patients with mild to moderate reduction of renal function, without any major impact on the pharmacokinetics of citalopram. At present no information is available for treatment of patients with severely reduced renal function (creatinine clearance &lt;20 mL/min).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Acute toxicity</u><br />Citalopram has low acute toxicity.<br /><u>Chronic toxicity</u><br />In chronic toxicity studies there were no findings of concern for the therapeutic use of citalopram.</p><p><u>Reproduction studies</u></p><p>Based on data from reproduction toxicity studies (segment I, II and III) there is no reason to have special concern for the use of citalopram in women of child-bearing potential.</p><p>Embryotoxicity studies in rats with doses of 56 mg/kg/day, which cause maternal toxicity showed bone anomalies in the region of the vertebral column and ribs. The maternal plasma level was then 2-3 times the therapeutic concentration in man. In rats citalopram did not have any effect on fertility, pregnancy and postnatal development but diminished the birth weight of the pups. Citalopram and its metabolites reach foetal concentrations, which are 10-15 times the maternal plasma level.</p><p>Animal data have shown that citalopram induces a reduction of fertility index and pregnancy index, reduction in the implantation number and abnormal sperm at exposure well in excess of human exposure.</p><p><u>Mutagenic and carcinogenic potential</u></p><p>Citalopram has no mutagenic or carcinogenic potential.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mannitol, Microcrystalline Cellulose, Colloidal Anhydrous Silica, Magnesium Stearate, Purified water, Hypromellose, Titanium Dioxide and Macrogols (PEG-6000).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium/PVC Blister; Box of 2 strips of 14 Tablets each.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oman Pharmaceutical Products Co. L.L.C.
Plot no 108
Raysut Industrial city, 
P.O Box 2240 Postal code 211
Salalah,Sultanate of Oman
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>